Buy Antibiotics Online

This post is a response to a question from someone about going into healthcare late in life and in the economic turmoil of today.
I absolutely say go for it, but of course I am biased. There are a couple of aspects to your question. The first one is concerning your age and my answer is that it doesn’t matter. Over thirty really isn’t that far behind. The average age of the students in my class at the beginning of the year was almost 25. I have met several people that are on their second career and some of them are over thirty. We even have one or two people in our first year medical Continue reading

) plan to become a leader in biotech drugs and widen its footprint in emerging markets created plenty of buzz last week, underscoring the importance pharma puts on developing new and better business models.
The nation's No. 2 drug maker unveiled its plan Dec. 9 at its annual business briefing with analysts. Much of the attention centered on Merck's announcement of a new division, Merck BioVentures, that will make new and generic biotech drugs.
The company also said it's on track to reach a goal of $2 billion in annual sales from emerging markets such as Brazil, China and India. Merck eyes more Continue reading

. It's based on a Rand survey of 4,000 U.S. adults that shows the following:
Fifty-three percent of all adults surveyed have no intention of getting the flu vaccine this year, while 17 percent say they haven't yet but will at some point.
Seventy percent of healthy adults under age 50 have no intention of being vaccinated, while 16 percent say they will at some point but haven't yet.
Public-health experts are up in arms, saying that it's a
on our nation's health report card. Yet, I'm not quite sure what the brouhaha is about. After all, the Centers for Disease Control and Prevention
—only Continue reading